🇺🇸 FDA
Patent

US 6844004

Topical formulations of natamycin/pimaricin

expired A61KA61K47/10A61K47/12

Quick answer

US patent 6844004 (Topical formulations of natamycin/pimaricin) held by The Board of Regents of the University of Texas System expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/10, A61K47/12, A61K47/20, A61K47/26